OrganoClick AB (publ)

ORGC.ST

Chemicals - Specialty · Basic Materials

Price

kr 0.37

-0.02 (-5.08%)

Market Cap

kr 68.5M

Exchange

Stockholm Stock Exchange

Winston Score

Winston is worried

Weak fundamentals across most pillars.

Data as of Aug 23, 2026 · filings through Jun 30, 2026

How the score breaks down

Quality

Weak

Growth

Weak

Cash Flow

Weak

Stability

Weak

Valuation

Data not available

Track this stock — start free trial

Share count rising — dilution

+6.3% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 95.9M (2021) → 101.9M (2025)

Winston Score History

The full picture

OrganoClick is a Swedish specialty chemicals company that makes bio-based and environmentally friendly materials. Its core products include water-repellent treatments for textiles and wood, as well as fiber-based composites and packaging materials. The company focuses on replacing traditional petroleum-based or harmful chemicals with alternatives made from natural raw materials like cellulose and chitosan.

OrganoClick earns revenue by selling its chemical products and materials to manufacturers in industries like outdoor textiles, construction, and packaging. It operates primarily in Sweden and the broader European market and is a small company with a market cap below $50 million. Its competitive angle is its patented green chemistry technology, but the business is currently unprofitable, with operating margins deeply negative, which means it burns more cash than it earns. The key risk is whether it can scale sales fast enough to reach profitability before needing to raise more capital from investors.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-26.3% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+43.5% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

kr 2M/ year

↓ Declining (-74% vs prior year)

1.4% of revenue

Below sector average (3%)

R&D spend declining — could signal cost-cutting or efficiency

Insider Activity

74.7%ownership

↑ Rising

Insiders increasing their stake — aligned with shareholders

Cash Position

Cash flow positive

kr 4M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Revenue declining

OrganoClick AB (publ)'s revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

28.6%

Modest — 28.6% gross margin

Profit after running costs

Operating Margin

-9.6%

Losing money on operations — -9.6%

Return on the money invested

ROCE

-36.8%

Weak — -36.8% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

-22.0%

Shrinking sales (-22.0% YoY)

Profit growth

EPS YoY

N/A

—

Data not available

How steady the profit is

EPS Consistency

2/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

N/A

—

Data not available

Spare cash per sale

FCF Margin

-8.1%

Burning cash (-8.1%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

5.91

Heavy debt load (5.91)

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

—

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial